You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
盤龍藥業(002864.SZ):與西安醫學院簽署合作框架協議
格隆匯 01-18 19:28

格隆匯1月18日丨盤龍藥業(002864.SZ)公佈,公司近日與西安醫學院達成戰略合作協議。雙方擬通過各自資源在多個領域開展合作。協議主要涉及合作內容如下:

(1)公司與西安醫學院共同建立現代化康復醫院。在公司註冊地陝西省商洛市柞水盤龍生態產業園,公司與西安醫學院共同合作新建一所二級甲等醫院,冠名為西安醫學院附屬秦嶺醫院(暫定名)。西安醫學院負責投入醫療管理團隊和專家隊伍建設,在醫療業務、學科建設、醫院運營上進行全面管理,公司負責新建醫院的基礎設施建設及設備投資,使新建醫院具備開辦條件。

(2)公司與西安醫學院共同建設西安醫學院護理與康復學院新院區。基於產教融合下的高校與企業深度合作,以打造“陝西康養、康護人才培訓、培養搖籃”為目標,共同培訓、培養康養、康護專業化、高端化康復護理人才。

(3)公司與西安醫學院二級學院、附屬醫院搭建產學研合作平台。公司與西安醫學院就經典名方、院內製劑品種開展研究,並申報新藥轉化。在政策允許的前提下,西安醫學院支持附屬醫院及其醫聯體與公司子公司陝西盤龍醫藥股份有限公司在醫藥配送業務方面進行合作,擴大雙方合作的影響力。

(4)公司通過在西安醫學院設立專項醫學基金方式,每年支付100萬元人民幣為西安醫學院人才培養提供資金支持。

(5)公司與西安醫學院持續推進“產學研扶貧”合作。為鞏固脱貧攻堅成果,雙方深化協作交流,持續推進產學研扶貧項目合作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account